Herbert Virgin - 09 Aug 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: EVP, Research & CSO
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 09 Aug 2022
Net transactions value: +$189,658
Form type: 4
Filing time: 10 Aug 2022, 16:50:49 UTC
Previous filing: 11 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$107,371	+70,177	+38%	$1.53^*	254,584	09 Aug 2022	Direct
transaction	VIR	Common Stock	Options Exercise	$82,287	+7,916	+3.1%	$10.40	262,500	09 Aug 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-70,177	-33%	$0.000000	140,328	09 Aug 2022	Common Stock	70,177	$1.53	Direct	F1
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-7,916	-5.9%	$0.000000	125,416	09 Aug 2022	Common Stock	7,916	$10.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is fully vested and exercisable.
F2	1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.